Stable Salt of 5,10-Methylene-(6R)-TETRAHYDROFOLIC Acid
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,122,783 | Stable Salt of 5,10-Methylene-(6R)-TETRAHYDROFOLIC Acid In force · Medium confidence | Merck & Cie | In force | Medium confidence | ||
| Application 14/912,328 | New Stable Salt of 5,10-Methylene-(6R)-TETRAHYDROFOLIC Acid Abandoned Abandoned Dec 7, 2018 | Merck & Cie | Abandoned | Abandoned Dec 7, 2018 | ||
| Application 16/212,056 | New Stable Salt of 5,10-Methylene-(6R)-TETRAHYDROFOLIC Acid Abandoned Abandoned Oct 12, 2021 | Merck & Cie | Abandoned | Abandoned Oct 12, 2021 | ||
| Application 18/799,606 | New Stable Salt of 5,10-Methylene-(6R)-TETRAHYDROFOLIC Acid Merck & Cie KMG Pending Not granted | Merck & Cie KMG | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Merck & Cie.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.